Background: Mesenchymal stem cells (MSCs) are promising candidates as a cell-based therapy for osteoarthritis (OA), although current results are modest. Pre-treatment of MSCs before application might improve their therapeutic efficacy.
Osteoarthritis (OA) is characterized by an inflammatory and catabolic intra-articular environment, which causes progressive degeneration and inflammation of multiple intra-articular tissues. Sport-related injuries like anterior cruciate ligament ruptures or meniscal tears increase the incidence of OA. 2, 50 To date, only symptomatic treatments are available for OA. A successful strategy to cure OA would consist of long-term modulation of the degenerative joint environment by simultaneously reducing inflammation and promoting tissue regeneration. Mesenchymal stem cells (MSCs) are promising candidates for this therapeutic approach to OA. They have been shown capable of suppressing immune-mediated cartilage destruction while contributing to cartilage repair via their chondrogenic differentiation and paracrine stimulation of endogenous repair processes. 8, 16, 27, 33 The use of MSCs as cell therapy for OA by intra-articular injection has been reported to be safe. 4, 34 However, clinical trials and preclinical studies did not show consistent data on healing or regeneration of damaged tissues after MSC treatment. 4, 48 A possible explanation for these inconsistent results could be the fast decrease in the number of viable MSCs after injection in the joint; no viable MSCs were detected in the joint 1 to 2 weeks after injection. 44, 46 A small proportion of intra-articularly injected MSCs attached to synovial surfaces after these injections, but almost none attached to the affected cartilage. 32 During their rather short local intra-articular presence, MSCs can have only a small effect. In cardiology, it has been shown that providing a longer interplay between the diseased tissue and applied MSCs increased the therapeutic effect. 31, 49, 53 We hypothesized that pre-treatment of MSCs with inflammatory factors or hypoxia would improve their migration and adhesion capacities toward OA affected tissues.
The migration and adhesion of injected MSCs in OA joints will depend on multiple considerations, including the chemotactic factors secreted by OA joint tissues, the expression of chemotactic receptors for these factors, and the expression of cell adhesion receptors by the MSCs. 3, 13, 14, 16, 21, 23, 24 In OA joints, the presence of multiple chemokines that can attract MSCs has been described. 3, 6 Furthermore, multiple chemokine receptors and adhesion receptors have already been indicated as possible migration receptors and adhesion receptors of MSCs. 3, 16, 19, 35, 39, 43, 51, 54 Previous studies showed that the expression of these migration receptors can be influenced by exposure to inflammatory factors 16, 18, 35, 37 or hypoxia, 10, 22 but none of these studies evaluated the effect on intra-articular migration or adherence. Moreover, exposure of MSCs to inflammatory factors increases their immunomodulatory capacities 15, 28, 38, 41 and was previously shown by us to increase the anti-inflammatory and anticatabolic effects of MSCs on inflamed osteoarthritic joint tissues in culture. 47 In the current study, we evaluated whether OA synovium and cartilage produce chemotactic factors that can stimulate MSCs to migrate and adhere to the OA-affected tissues after injection and whether we could influence MSC migration capacities in vitro and adhesion capacities in vivo. Abbreviations used in the article are defined in Table 1 .
METHODS
Harvesting OA Synovial Fluid and Conditioned Medium of OA Synovium and Cartilage Human SF, cartilage explants, and synovial explants were obtained as surgical waste material from patients undergoing total knee replacement surgery for OA. All patients implicitly consented to the use of these tissues for scientific research (with approval of medical ethical committee, MEC-2004-322) . Schematic overviews of all methods used are depicted in Appendix Figures A3 and A4 , available in the online version of this article.
To remove debris, SF samples were centrifuged (1600 rpm, 5 minutes), and supernatant was subsequently stored at 280°C. Full-thickness layers of uncalcified cartilage of macroscopically unaffected areas were taken from weightbearing and nonweightbearing parts of the tibial plateau and femoral condyles. The synovial layer was carefully dissected from Hoffa's fat pad, with care taken to include as little fat tissue as technically possible. The cartilage and synovium explants were cut in 1-4 mm 2 pieces. To generate CM, 1 g of tissue was cultured per 5 mL for 24 hours in medium we used previously, 5 which consisted of low-glucose DMEM (Invitrogen) containing 1% ITS (BD Bioscience), 1.5 mg/mL Fungizone (Invitrogen), 50 mg/mL gentamicin (Invitrogen), and 0.1 mM L-ascorbic acid 2-phosphate (vitamin C) (Sigma). CM was harvested after 24 hours and centrifuged (1200 rpm, 8 minutes), and the supernatant was stored at 280°C. 
Isolation and Culture of MSCs
MSCs were isolated from heparinized femoral-shaft marrow aspirate of patients undergoing total hip arthroplasty, after signed informed consent and with approval of the local ethical committees. Five to 10 mL of marrow was harvested with sterile Jamshidi needles and sterile 10-mL syringes containing 0.5 mL of heparin (1000 U/mL). Mononuclear cells (30-100 3 10 6 ) were plated in T175 flasks in 25 mL of expansion medium consisting of aMEM (Invitrogen) containing 10% heat inactivated FCS (Lonza; selected batch), 1.5 mg/mL Fungizone, 50 mg/mL gentamicin, 1 ng/mL FGF2 (Instruchemie B.V.), and 0.1 mM vitamin C. After 24 hours, nonadherent cells and erythrocytes were removed by washing 3 times with 2% FCS in 31 PBS (Invitrogen). Remaining adherent cells were cultured in expansion medium at 37°C and 5% carbon dioxide. Expansion media were renewed twice a week. Cells were trypsinized at subconfluency with 0.25% trypsin solution containing 0.01% EDTA (Invitrogen) and were replated at a density of 2300 cells/cm 2 . To evaluate whether different FCS batches or PL, generally used for MSC culturing, influence the migration or adhesion factor expression in MSCs, cryopreserved passage 2 MSCs (n = 3 donors) were used. MSCs were expanded for 1 passage in 3 different 10% FCS batches with 3 different lot numbers of the same company (Lonza; selected batches) and PL (.50 pooled human donors prepared as described previously 33 ) in expansion medium. Before use, PL was thawed and centrifuged at 2000g for 10 minutes to remove remaining platelet fragments. After centrifugation, PL was stored at 4°C and used for up to 1 week. After passaging, the MSCs remained in their specific serum condition for another 72 hours, with a final medium change 24 hours before harvesting for gene expression analysis.
To study the effect of OA SF and the effect of exposure to inflammatory factors and hypoxia, passage 2 MSCs were thawed and expanded for 1 passage. MSCs (n = 3 donors) were plated in 6-well plates and at 70% confluence were washed with PBS and cultured for 48 hours in low-glucose DMEM containing 20% OA SF, 1% ITS, 1.5 mg/mL Fungizone, 50 mg/mL gentamicin, and 0.1 mM vitamin C. 29 After 48 hours, MSCs were harvested for gene expression analyses. To evaluate the effect of hypoxia and inflammatory factors, MSCs were plated in 6-well plates (2 3 10 5 cells/well) and cultured in expansion medium for 48 hours under 20% of oxygen (normoxic) or 1% of oxygen (hypoxic) conditions. After 48 hours, cells were washed with PBS and cultured for 24 hours in low-glucose DMEM containing 1% ITS, 1.5 mg/mL Fungizone, 50 mg/mL gentamicin, and 0.1 mM vitamin C with an additional 1 ng, 20 ng, or 50 ng IFN-g and TNF-a (PeproTech) per milliliter. MSCs were kept in their normoxic or hypoxic state and subsequently were harvested for gene expression analyses; CM was harvested, centrifuged, and stored at 280°C. The choices for concentrations of inflammatory factors and exposure time to hypoxia and inflammatory factors were made based on the literature and our own experiments. 10, 11, 40, 47 Gene Expression Analysis Total RNA from MSCs was isolated by use of the RNeasy microkit with RNeasy MinElute spin columns (Qiagen). After nucleic acid quantification by spectrophotometry (NanoDrop 2000; Thermo Scientific), RNA was reversetranscribed by means of a first-strand cDNA synthesis kit (RevertAid; MBI Fermentas). Amplifications were performed as 10-mL reactions in a CFX96 real-time thermal cycler (Bio-Rad Laboratories). Thermocycler conditions comprised an initial holding at 95°C for 10 minutes, followed by one step at 95°C for 15 seconds and 60°C for 60 seconds for 40 cycles. A dissociation stage was added at the end using 95°C for 15 seconds, 60°C for 20 seconds, and 95°C for 15 seconds. For HPRT, TaqMan Master Mix (ABI) was used. For receptor expression for chemotactic factors, TaqMan universal Master Mix (Life Technologies) was used for receptors CCR1, CCR4, CCR5, PDGFRa, PDGFRb, CXCR1, CXCR3, CXCR4, CX3CR1, and adhesion factors ITGb1, ITGb2, and homing cell adhesion molecule CD44. Primers and probes used in this study are depicted in Table  2 . Genes were detected using TaqMan assays on demand (Life Technologies). Data were quantitatively analyzed on CFX manager software (version 3.1, Bio-Rad). Gene expressions in MSCs were calculated by CT values. CT values of 36 or higher were considered nonexpressed and were set to 100 for further calculations. CT values were corrected for housekeeper gene HPRT by using the 2 -DCT formula.
Migration Assay
The migration assay was performed with 24-well-plate transwell inserts (Millicell, inserts 8.0 mm PET, Cat. No. PIEP12R48; Merck Millipore). OA cartilage CM (pooled from 6 donors), OA synovium CM (pooled from 6 donors), and control medium consisting of low-glucose DMEM, 1% ITS, 1.5 mg/mL Fungizone, 50 mg/mL gentamicin, and 0.1 mM vitamin C were placed in the wells (600 mL/well).
Each condition was performed in 6 wells. Transwell inserts were placed in the wells, and 6 3 10 3 passage 2 MSCs in 200 mL of control medium were plated in the transwell insert and incubated for 18 hours. Then, transwell inserts were harvested and the medium was discarded. The bottoms of the wells were checked for adherent MSCs to exclude missed migrated cells. The inserts were washed with PBS, and cells on the insert membrane (inside and outside) were fixed with 10% formalin for 30 minutes, permeabilized with 0.1% Triton X-100 for 5 minutes, and washed with Milli-Q (Millipore). Cells were stained by placing the inserts in toluidine blue for 60 seconds followed by a quick rinse in Milli-Q. The inner side of the membrane was swabbed with a cotton wool swab to remove nonmigrated MSCs. Microscopic pictures of MSCs that migrated to the outer side of the transwell membrane were taken directly after the swab. Migrated cells were counted at a 3200 magnification by using an inlay raster and 9 preset standardized fields for the membranes. Based on these counts, the total number of cells per square centimeter could be calculated and extrapolated to the total surface of the membrane. With this method, the number of migrated cells per condition could be determined.
In Vivo Cell Adhesion in OA Knees and Healthy Rat Knees
The animal experiments were approved by the animal ethical committee (EMC2285 116-11-03). The animals were housed in groups of 2 animals per individually ventilated cage (21 3 37 cm) in sawdust that was enriched with nesting material. The animals had food and water ad libitum with a light-dark cycle of 12 hours. Discomfort and welfare were evaluated and scored daily by the animal caretakers. Animals were allocated to the OA or control group at random. OA was induced bilaterally in the knees of 13-weekold male wild-type Wistar rats (n = 5) (Harlan Netherlands BV) by an intra-articular injection of 20 mL of saline containing 1 mg of MIA. Healthy controls, 13-week-old male wild-type Wistar rats (n = 5), were bilaterally injected intra-articularly in the knee with 20 mL of saline. All injections and imaging procedures were applied under isoflurane inhalation anesthesia (Pharmachemie BV) while monitoring cardiac function, with additional subcutaneous injections of 0.01 mg/kg buprenorphine during and 1 day after intra-articular injections. MIA injections cause structural damage after 3 weeks, 42 and at that point MSCs were injected via the intra-articular route.
Passage 3 MSCs were labelled at 80% to 90% confluency with SPIO by incubating the MSCs for 24 hours in aMEM with 5% FCS, ferumoxides 100 mg/mL (11.2 mg Fe/mL; Endorem, lot/batch 08GE601A), and protamine sulphate 5 mg/mL (LEO Pharma). 45 Labelled cells were trypsinized and plated at a density of 2 3 10 4 MSCs/cm 2 . After 48 hours, MSCs were exposed to 50 ng/mL IFN-g and 50 ng/mL TNF-a (IFN-g/TNF-a) in expansion medium or cultured in normal expansion medium (nonactivated) for 24 hours. After 24 hours, MSCs were washed with PBS and trypsinized. A 50-mL syringe (Hamilton) was used for intra-articular injection of 1 3 10 6 MSCs in 20 mL of saline. This number of MSCs (1 3 10 6 ) was selected based on literature that reported the effect of this cell number and side effects of higher numbers of cells. 1, 20, 46 At 24 hours after injection, SPIO-MSCs were visualized with a preclinical 7.0-T MRI scanner (MR 901 Discovery; Agilent/GE Healthcare). Cell attachment and migration were evaluated after 24 hours of injection since we expected attachment and migration processes to take place in the first 24 hours. Directly after the scan, the rats were sacrificed by a pentobarbital overdose, and the knees were harvested for histologic evaluation.
Tissue Harvest and Histologic Evaluations
All knees (n = 20 knees) were fixed in formalin 4% (vol/vol) at room temperature for 1 week, decalcified in 10% EDTA at room temperature for 3 weeks, and embedded in paraffin. Coronal sections were stained with thionin to evaluate cartilage damage. 46 Perls iron staining was done for localization of SPIO-MSCs. All samples were blinded before scoring, and 2 different histologic sections of each knee 
Statistics
Effects of different FCS batches, PL, inflammatory factors, hypoxia, and OA SF on gene expression of chemotactic receptors genes were analyzed with a mixed-model analysis of variance (ANOVA), which takes into account correlation within donors. Cell migration was analyzed with a separate ANOVA linear regression model for MSCs with and without exposure to inflammatory factors. Post hoc, independent, 2-tailed t tests were performed to compare conditions within both groups. The effect of MIA on MSC adhesion to different OA tissues in vivo was determined by independent 2-tailed t tests. P values of .05 were considered statistically significant. Analyses were performed using SPSS 21.0 (SPSS Inc).
RESULTS

Chemokines in the Synovial Fluid and Secreted by OA Tissues In Vitro
To evaluate chemokine secretion by cartilage and synovium, we conducted a 10-plex Milliplex assay on CM of OA synovium and cartilage and on OA SF. The 10 selected factors were detected in all conditions (Table 3) . High levels of MCP-1 and IL-8 were secreted by synovium and cartilage. Furthermore, synovium secreted high amounts of MIP-1a and MIP-1b, whereas cartilage secreted high amounts of PDGF-AA and IP-10. The mRNA of the receptors for these chemokines was expressed in cultured MSCs. CD44, PDGFRa, and PDGFRb were highly expressed (CT 25); CCR1, CCR4, CCR5, CXCR3, and CX3CR1 were intermediately expressed (CT = 26-36); and CXCR1 was not expressed (CT 36).
Expression of Migration and Adhesion Factors in MSCs Is Independent of Serum Used in Culture
During culture, the MSCs are generally exposed to serum. Different laboratories use different batches of FCS. Moreover, the use of pooled batches of human PL has become increasingly popular. Serum could potentially influence cell behavior and could make comparison between results obtained in different laboratories difficult. We evaluated the expression of known migration receptors PDGFRa, PDGFRb, CCR1, and CCR4 and adhesion receptors ITGb1, ITGb2, and CD44 in MSCs expanded in 3 different batches of FCS and a batch of pooled human PL. Different culture sera did not significantly affect the expression of migration receptors CCR1, CCR4, PDGFRa, and PDGFRb or the expression of the adhesion receptors CD44 and ITGb1 in MSCs (Figure 1) .
Influence of Inflammation, Hypoxia, and OA Synovial Fluid on MSC Migration/Adhesion Receptors
To evaluate whether a short treatment in culture could increase expression of migration or adhesion receptor genes in MSCs, we exposed the cells to the combination of inflammatory factors IFN-g/TNF-a or cultured the cells in hypoxia (1% oxygen). Furthermore, we determined whether OA SF would influence expression of the aforementioned genes. Exposure of MSCs to different concentrations of Chemokine secretion by osteoarthritic synovium and cartilage for 24 hours in medium and chemokine content in osteoarthritic synovial fluid in pg/mL. Undetectable and below-minimum detectable concentrations values were set at 50% of the minimum detectable concentration value. n = 6 donors.
IFN-g/TNF-a upregulated the expression of CCR1, CCR4, and CD44, whereas PDGFRa and PDGFRb were downregulated by the inflammatory factors (Figure 2 ). The other migration receptor genes, CCR5, CXCR1, CXCR3, CXCR4, and CX3CR1, and the adhesion receptor genes, ITGb1 and ITGb2, were not influenced by inflammatory factors (data not shown). Hypoxia did not have any effect on the gene expression of the migration receptors and adhesion receptors studied, either in the presence or absence of IFN-g/TNF-a (Appendix Figure A1 , available online). Finally, we observed an upregulation of gene expression of only PDGFRb (P = .006) in MSCs by OA SF (Appendix Figure A2) .
MSC Migration Toward Factors Secreted by OA Tissues
We evaluated whether MSCs would migrate to factors secreted by OA synovium or cartilage and whether this was influenced by pre-treatment of MSCs with the combination IFN-g/TNF-a. MSCs migrated more toward OA synovium CM and OA cartilage CM compared with control medium for both nonactivated (P .001) and activated MSCs (P \ .001), indicating that OA cartilage and synovium secreted factors that stimulated MSC migration (Figure 3) . No significant effect of pre-treatment of MSCs was found (P = .060). Nonactivated MSCs migrated more toward synovium CM compared with cartilage CM (P = .031), and a comparable trend was observed for MSCs activated by inflammatory factors (P = .065).
In Vivo Adhesion of Nonactivated MSCs and Activated MSCs in Healthy Knees or OA Knees
An in vivo experiment was performed to study MSC migration and attachment to synovium and cartilage. All animals used were wild-type male Wistar rats that were healthy before the study, and no side effects or health problems were found during the study. We evaluated whether there was a difference between activated and nonactivated MSCs in their migration and adherence patterns and whether this was influenced by the presence or absence of OA. MSCs were found attached to synovium or cartilage or were present as free cells in the joint space ( Figure 4E ). Cartilage damage and synovial inflammation were clearly visible after OA induction by the MIA model (modified Pritzker score 20.4 6 4.84) and were absent in control knees (modified Pritzker score 4.4 6 1.27) (P \ .001) (Figure 4A, 4B) . At 24 hours after injection, MSCs were present in all control and OA knees. MSCs were mostly found attached to synovium (semiquantitative score 3.13 6 1. 19) or located freely in the joint space (semiquantitative score 3.95 6 1.25); this was approximately equally distributed based on our semiquantitative scoring system. Since very small amounts of cells were found attached to cartilage (semiquantitative score 1.03 6 0.11) (Figure 4D ), we evaluated only MSC attachment to synovium to compare healthy versus OA knees and to evaluate the effect of MSC pre-treatment with inflammatory factors. We could not detect significant differences in MSC attachment to synovium between OA and healthy knees or an effect of pre-treatment with inflammatory factors (Figure 4F, 4G ).
DISCUSSION
We investigated whether MSCs migrate to OA tissues and whether this migration could be influenced by adapting the culture conditions before application of MSCs. Both OA synovium and OA cartilage secreted substantial amounts of chemokines. The profile of the secreted chemokines varied between both tissues. We showed that MSCs express migration and adhesion receptor genes and migrate to factors secreted by both OA synovium and cartilage in vitro. In vivo, more MSCs attached to synovium than to cartilage. The expression of migration and adhesion receptors was altered by adding inflammatory factors during culture, although this did not influence migration in vitro or adhesion in vivo.
Throughout the world, laboratories use different batches of FCS to culture MSCs. Human PL is often used and is described to have a positive effect on proliferation and differentiation of MSCs. 25 However, contradictory results have been published regarding the effect of culturing with PL on the migration/adhesion capacity of MSCs and the migration of MSCs toward PL. 17, 33 We compared the effects of 3 different batches of FCS and a batch of pooled PL on gene expression of migration and adhesion receptors in MSCs. Our results indicate that different FCS batches or PL will not likely have a differential effect on migration and attachment of MSCs, such that the use of different sera in expansion culture is less likely to be a confounder for migration and adhesion in the comparison of different studies with intra-articularly injected MSCs.
Next to the capacities of MSCs to differentiate and regenerate damaged tissue, their immunomodulatory and trophic properties are very important for their therapeutic function in OA. MSCs need to be activated with inflammatory factors like IFN-g and TNF-a to secrete immunomodulatory and trophic factors. 15, 28, 38, 41 This immunomodulatory and trophic capacity is maintained under hypoxic conditions, 30, 40 which is important because MSCs used as cell therapy for OA will be injected in a hypoxic joint environment. We showed no effect of hypoxia on the expression of migration or adhesion receptor genes in MSCs. It is not clear what the levels of hypoxia are in joints, but for culture, hypoxia levels range from 1% to 5% oxygen. We chose 1% oxygen based on previous studies and experiments in our laboratory.
10,40 A different oxygen level might have different effects. It is known that inflammatory factors can upregulate chemokine receptors in MSCs in vitro. 16, 18, 35, 37 We hypothesized that these inflammatory factors could also improve the migration and adhesion of MSCs to OA tissues. Indeed, exposure to a combination of inflammatory factors IFN-g and TNF-a upregulated gene expression of CCR1 and CCR4, although PDGFRa and PDGFRb were downregulated. Chemokines that bind to CCR1 and CCR4 (ie, MIP-1a, MIP-1b, MCP-1, MCP-3) were found in a higher concentration in synovium CM compared with cartilage CM. These chemokines can increase MSC migration. 7 Since the receptors that bind these chemokines are upregulated in MSCs by pre-treatment with IFN-g/TNF-a, we would expect better attachment and migration to synovium. Nevertheless, this was not confirmed in vitro or in vivo, where cell pre-treatment with IFN-g and TNF-a did not improve functional migration of MSCs to synovium. PDGFb, a chemokine that binds to PDGFRb and indirectly interacts with PDGFRa, was more abundantly found in cartilage CM. There was less MSC attachment and migration to cartilage, although pre-treatment with IFN-g and TNF-a did not decrease the cell attachment and migration. These results are in line with a recent report on MSC homing in a mouse hypoxic gut model. 26 We cannot exclude that longer or shorter exposure to culture conditions or different concentrations of inflammatory factors or oxygen might have had an effect. In our study, the absolute migration was even slightly decreased in vitro, although the activated cells still migrated toward factors secreted by OA tissues. We excluded that cell death due to treatment with the combination of 50 ng/mL IFN-g/50 ng/mL TNF-a could explain the decreased absolute migration found, since exposure to these factors did not decrease cell survival after 24 hours. However, we have not evaluated whether the immunomodulatory properties of MSCs pre-treated with IFN-g/TNF-a were indeed increased in vivo. This will need careful consideration before future applications, since Kavanagh et al 26 recently found a decreased vasculoprotective effect in vivo of MSCs pre-treated with IFN-g or TNF-a.
There are several limitations to our study. We used human MSCs from relatively aged OA donors who underwent total Figure 3 . MSC migration toward factors secreted by OA synovium and OA cartilage in a transwell migration assay. Data are shown as mean 6 SD. ''Nonactivated'' MSCs were cultured in normal expansion medium for 24 hours; ''activated'' MSCs were exposed to the combination of 50 ng/mL IFN-g/50 ng/mL TNF-a in medium for 24 hours.
hip arthroplasty. Although these MSCs might be considered less potent in vivo compared with rat MSC from young donors, we consider this cell type to be more clinically relevant, being better predictive of expected results in future clinical application. We used cartilage and synovium of 6 different donors and MSCs of 3 donors. Donor variability should always be taken into account. The level and the variation we have seen in the chemokine data are comparable to the variation we have seen in previous studies. 6, 9 The effect of inflammatory factors or hypoxia on chemokine and adhesion receptor expression was not large on all MSC donors. Therefore, we consider our conclusions valid. Furthermore, cells were labelled using SPIO for tracking purposes by MRI and histologic evaluation. SPIO labelling could have an effect on cell migration and adhesion capacities. 12, 52 Although in previous studies we did not find effects of our labelling procedure on cell viability, differentiation, and secretion of immunomodulatory factors, 47 and we confirmed that the cells were viable and adherent when cultured on tissue culture plastic, we cannot completely rule out an effect. Migration and adherence of the cells were evaluated 24 hours after injection. These processes are expected to take place in the first 24 hours. We realize that this time window is not sufficient to study the many processes that might happen afterward, such as cell proliferation, cell invasion into tissues, and cell death. We assume that cells will not attach when they shown as mean 6 SD. CL, cruciate ligament; F, femur; P, patella; T, tibia; S, synovium. ''Nonactivated'' MSCs were cultured in normal expansion medium for 24 hours; ''activated'' MSCs were exposed to the combination of 50 ng/mL IFN-g/50 ng/mL TNF-a in medium for 24 hours.
have died during injection or during the first hours after injection. The attached cells were scored on histologic evaluation by a semiquantitative score, which can be not accurate enough to quantify eventual differences between the groups.
MSCs migrated more toward factors secreted by OA synovium compared with cartilage. In line with this, more cells attached to synovium than to cartilage in vivo. This could be explained by both chemoattractive and mechanical processes. Overall, chemotactic factors were found in a higher concentration in synovial CM compared with cartilage CM. Care should be taken, however, to directly compare the levels of factors secreted by synovium and cartilage in our studies. Although synovium CM and cartilage CM were made in a standardized way, based on wet weight of tissue per volume, synovial tissue contains substantially more cells per gram of wet weight than cartilage tissue. Nevertheless, we can conclude that both synovium and cartilage secrete high amounts of chemokines, and the profile of the secreted chemokines seems to differ between synovium and cartilage. The factors secreted by cartilage and synovium were also found in synovial fluid. In a previous study we found that the levels of MDC, PDGF-AA, IP-10, CCL5, and MIP-1b were higher in OA than in control SF, 6 which would indicate higher chemotactic effects of osteoarthritic tissues. Nevertheless, no differences in migration or adhesion were seen between rat knees with and without OA. The synovial fluid did not affect the receptor gene expression in MSCs (Appendix Figure A2 ), but we did not evaluate whether the secreted factors individually could affect the gene expression or function of MSCs. Another explanation for better adhesion of MSCs to synovium compared with cartilage could be the continuous movements of the joint that might evoke shear stresses that MSCs cannot resist, especially those that primarily attached to cartilage. Furthermore, cells are more likely to attach to a rough surface like synovium than to a smooth surface like cartilage. Nevertheless, in our OA model with marked cartilage damage, no improvement of cell adhesion to cartilage was seen. We assume that intraarticular cell attachment is influenced by a combination of chemoattractive processes, tissue surface characteristics, and biomechanics.
CONCLUSION
Intra-articular tissues affected by OA secrete chemotactic factors that can attract MSCs. Exposure to inflammatory factors influenced MSC gene expression of several chemokine receptors, although these inflammatory factors did not affect the migration of MSCs in vitro or MSC attachment in vivo.
